MOLOGEN AG appointed Walter Miller as member of the Executive Board and new Chief Financial Officer with effect from 1 April 2016. Upon taking office, Walter Miller will have responsibility within the company for Finance and Administration as well as the Risk Management, Compliance and Corporate Governance departments. He is an excellent Chief Financial Officer with experience and expertise in the biotech and pharma industry.

In addition to his skills acquired in commercial roles, he also has extensive experience in licensing activities and capital market related topics. As part of previous roles, he has also overseen various financing transactions. His knowledge and experience will make a decisive contribution to advancing MOLOGEN's development from a research-based biotech company to a biopharmaceutical product company.

With more than 15 years of experience in the biotechnology and pharmaceutical sector, Walter Miller has worked at both start-ups and listed companies in Germany and abroad. He was most recently CFO on the management team of Nuvisan GmbH. He was responsible for Finance, Legal, Purchasing and IT at the company from June 2013.

Prior to joining Nuvisan, he held various managerial posts at the listed Santhera Pharmaceuticals Group. As Vice President Finance & Commercial Operations, initially in Germany as well as subsequently in Switzerland, he was also a member of the Group's management team.